Farallon Capital Management LLC Fibrogen Inc Transaction History

Farallon Capital Management LLC

$19.9 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$12.02 - $16.79 $6.66 Million - $9.31 Million	-554,353 Reduced 60.31%	364,764 $4.38 Million
Q4 2021 Feb 14, 2022	SELL	$9.93 - $15.39 $5.23 Million - $8.11 Million	-527,095 Reduced 36.45%	919,117 $13 Million
Q3 2021 Nov 15, 2021	BUY	$10.18 - $26.64 $74,161 - $194,072	7,285 Added 0.51%	1,446,212 $14.8 Million
Q2 2021 Aug 13, 2021	SELL	$18.57 - $35.68 $4.55 Million - $8.73 Million	-244,773 Reduced 14.54%	1,438,927 $38.3 Million
Q1 2021 May 17, 2021	SELL	$31.0 - $55.72 $6.71 Million - $12.1 Million	-216,300 Reduced 11.38%	1,683,700 $58.4 Million
Q4 2020 Feb 16, 2021	BUY	$37.09 - $48.97 $1.85 Million - $2.45 Million	50,000 Added 2.7%	1,900,000 $70.5 Million
Q3 2020 Nov 16, 2020	BUY	$40.47 - $45.5 $9.11 Million - $10.2 Million	225,000 Added 13.85%	1,850,000 $76.1 Million
Q2 2020 Aug 14, 2020	BUY	$32.57 - $42.83 $825,095 - $1.09 Million	25,333 Added 1.58%	1,625,000 $65.9 Million
Q1 2020 May 15, 2020	BUY	$23.3 - $45.96 $5.82 Million - $11.5 Million	249,667 Added 18.49%	1,599,667 $55.6 Million
Q4 2019 Feb 13, 2020	BUY	$34.58 - $48.06 $12.1 Million - $16.8 Million	350,000 Added 35.0%	1,350,000 $57.9 Million
Q3 2019 Nov 14, 2019	SELL	$36.98 - $48.45 $25.9 Million - $33.9 Million	-700,000 Reduced 41.18%	1,000,000 $37 Million
Q2 2019 Aug 14, 2019	BUY	$35.13 - $55.53 $27.6 Million - $43.6 Million	784,421 Added 85.67%	1,700,000 $76.8 Million
Q1 2019 May 15, 2019	BUY	$42.83 - $59.91 $7.09 Million - $9.92 Million	165,579 Added 22.08%	915,579 $49.8 Million
Q4 2018 Feb 14, 2019	SELL	$37.97 - $60.16 $24.5 Million - $38.8 Million	-645,000 Reduced 46.24%	750,000 $34.7 Million
Q3 2018 Nov 14, 2018	SELL	$56.3 - $67.25 $18.2 Million - $21.7 Million	-322,500 Reduced 18.78%	1,395,000 $84.7 Million
Q1 2018 May 15, 2018	BUY	$45.35 - $61.65 $2.72 Million - $3.7 Million	60,000 Added 3.62%	1,717,500 $79.3 Million
Q4 2017 Feb 14, 2018	BUY	$41.95 - $60.1 $23.4 Million - $33.5 Million	557,500 Added 50.68%	1,657,500 $78.6 Million
Q3 2017 Nov 14, 2017	BUY	$33.4 - $53.9 $36.7 Million - $59.3 Million	1,100,000	1,100,000 $59.2 Million

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $31.9M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.

Account